Our Ferrous Fumarate Tablets with Folic Acid represent pharmaceutical-grade nutritional supplementation designed to effectively combat iron deficiency anemia. Each sugar-coated tab...
Our Ferrous Fumarate Tablets with Folic Acid represent pharmaceutical-grade nutritional supplementation designed to effectively combat iron deficiency anemia. Each sugar-coated tablet contains precisely measured 200 mg Ferrous Fumarate I.P. and 0.4 mg Folic Acid I.P., creating a potent combination that ensures optimal iron absorption and utilization. The formulation strictly adheres to pharmacopeial standards, guaranteeing consistent potency and therapeutic reliability in every batch. The sugar coating serves dual purposes: improving palatability for better patient compliance while protecting against gastric irritation, making these tablets suitable even for sensitive patients. Manufacturing follows rigorous GMP guidelines, ensuring product safety, efficacy, and professional-grade quality for healthcare applications.
These tablets serve multiple healthcare sectors including hospital networks, clinical institutions, and public health organizations. Pharmaceutical distributors and wholesalers incorporate them into essential medicine portfolios for supply to retail pharmacies, clinics, and healthcare facilities. Government health initiatives utilize them in national nutritional programs targeting anemia prevention in vulnerable populations. The product demonstrates particular effectiveness in maternal and child health programs where combined iron and folate supplementation proves critical for healthy development. Healthcare providers across various settings value these tablets for their consistent quality and reliable therapeutic performance in both treatment and preventive care scenarios.
The business value of these Ferrous Fumarate Tablets lies in their proven reliability and widespread market acceptance, minimizing procurement risks for professional buyers. The standardized formulation ensures predictable therapeutic outcomes, building confidence among healthcare professionals and end-users alike. Excellent stability profile allows for extended shelf life and simplified inventory management, while optimized bulk packaging enhances logistics and storage efficiency. The combination therapy approach differentiates these tablets from simple iron supplements, providing added therapeutic value through comprehensive nutritional support. Established manufacturing standards and quality certifications assure consistent product performance and regulatory compliance across markets.
Key Features:
- Contains 200 mg Ferrous Fumarate I.P. and 0.4 mg Folic Acid I.P. per tablet
- Sugar coating for improved swallowing and reduced gastric discomfort
- Manufactured following strict GMP guidelines and quality protocols
- Stable formulation with extended shelf life for inventory flexibility
- Consistent potency meeting pharmacopeial standards
Benefits:
- Effective combination therapy for comprehensive anemia treatment
- Enhanced patient compliance through improved palatability
- Reliable therapeutic outcomes with standardized formulation
- Efficient inventory management with stable shelf life
- Professional-grade quality ensuring healthcare provider confidence